Acro Biomedical (ACBM) Retained Earnings (2015 - 2026)

Acro Biomedical has reported Retained Earnings for 12 years, with the latest figure at -$32.8 million in Q2 2026.

• On a quarterly basis, Retained Earnings changed 0.43% year-over-year to -$32.8 million in Q2 2026; TTM through Jun 2026 was -$32.8 million, a 0.43% change from a year earlier, with the FY2025 full-year figure at -$32.8 million, changed 0.31% from the prior year.
• Retained Earnings was -$32.8 million for Q2 2026 at Acro Biomedical, roughly flat from -$32.8 million in the prior quarter.
• The five-year high for Retained Earnings was $32.3 million in Q2 2023, with the low at -$32.8 million in Q2 2026.
• Average Retained Earnings over 5 years is -$9.7 million, with a median of -$32.6 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Retained Earnings soared 10931.45% in 2022, then slumped 201.05% in 2024.
• Over 5 years, Retained Earnings stood at $32.3 million in 2022, then sank by 200.99% to -$32.6 million in 2023, then slipped by 0.13% to -$32.7 million in 2024, then fell by 0.31% to -$32.8 million in 2025, then dropped by 0.2% to -$32.8 million in 2026.
• The last three Retained Earnings figures came in at -$32.8 million (Q2 2026), -$32.8 million (Q4 2025), and -$32.8 million (Q3 2025), per Business Quant data.